Skip to Main Content
ManagedCareEye.com
This website is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
  • Home
  • CE Activities
  • Faculty
  • Expert Updates
  • Outcomes
  • Resources

Diabetic Retinopathy/Diabetic Macular Edema (DR/DME) – Payer Implications Fact Sheet

July 3, 2024

Quick CE Payer Implications Fact Sheet

← Key Insights Infographic: Assessing Recent Advances for Enhanced Management of Retinal Diseases   ManagedCareEye.com Presents: Managed Care Consensus Recommendations to Facilitate Equitable Access and Optimal Outcomes for Retinal Diseases →
  • About Impact Education, LLC
  • Contact Us (IMPACT)
  • Mailing List (IMPACT)
  • Privacy Policy

Jointly provided by

Medical Education Resources Impact Education, LLC

Supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

NEW Publication

Assessing Variation in Payer Coverage of Anti-VEGF Therapies for Retinal Diseases

Read Now